Is mifepristone useful in psychotic depression?

被引：12

作者：

Carroll, Bernard J.

Rubin, Robert T.

机构：

[1] Pacific Behav Res Fdn, Carmel Valley, CA 93922 USA

[2] VA Greater Los Angeles Healthcare Syst, Dept Psychiat & Mental Hlth 116A, Los Angeles, CA USA

来源：

NEUROPSYCHOPHARMACOLOGY | 2006年 / 31卷 / 12期

关键词：

D O I：

10.1038/sj.npp.1301170

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：2793 / 2794

页数：2

共 8 条

[1]

[Anonymous], 2000, DIAGN STAT MAN MENT

[2] An open label trial of C-1073 (mifepristone) for psychotic major depression [J].

Belanoff, JK ;

Rothschild, AJ ;

Cassidy, F ;

DeBattista, C ;

Baulieu, EE ;

Schold, C ;

Schatzberg, AF .

BIOLOGICAL PSYCHIATRY, 2002, 52 (05) :386-392

[3]

FEINSTEIN A.R., 1987, CLINIMETRICS

[4] Clinical and biological effects of mifepristone treatment for psychotic depression [J].

Flores, BH ;

Kenna, H ;

Keller, J ;

Solvason, HB ;

Schatzberg, AF .

NEUROPSYCHOPHARMACOLOGY, 2006, 31 (03) :628-636

[5] The choice of antipsychotic drugs for schizophrenia [J].

Freedman, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (12) :1286-1288

[6] AN ASSESSMENT OF CLINICALLY USEFUL MEASURES OF THE CONSEQUENCES OF TREATMENT [J].

LAUPACIS, A ;

SACKETT, DL ;

ROBERTS, RS .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (26) :1728-1733

[7] Effectiveness of antipsychotic drugs in patients with chronic schizophrenia [J].

Lieberman, JA ;

Stroup, TS ;

McEvoy, JP ;

Swartz, MS ;

Rosenheck, RA ;

Perkins, DO ;

Keefe, RSE ;

Davis, SM ;

Davis, CE ;

Lebowitz, BD ;

Severe, J ;

Hsiao, JK .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (12) :1209-1223

[8]

Rubin RT, 2004, NEUROPSYCHOPHARMACOL, V29, pS203

← 1 →